Steve Pakola sold $29K of RGNX stock

Steve Pakola, Chief Medical Officer of REGENXBIO Inc. (RGNX), sold 2,161 shares of RGNX stock worth $29K, per an SEC Form 4 filed Jul 6, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Jul 2, 2026, 4 days before it was made public.

RGNX has moved -39.2% since the trade date, from $13.28 to $8.07 (Nov 9, 2026 close).